Form 4: Boston Scientific EVP John Bradley Sorenson Sells Shares Under 10b5-1 Trading Plan

John Bradley Sorenson, EVP of Global Operations at Boston Scientific, sold shares of common stock on February 18 and 19, 2025, under a pre-established Rule 10b5-1 trading plan.

Summary

• John Bradley Sorenson, an EVP at Boston Scientific, sold shares of the company's common stock.
• The sales occurred on February 18 and 19, 2025.
• These transactions were executed under a pre-established Rule 10b5-1 trading plan adopted on August 9, 2024.
• On February 18, 2025, 2,657 shares were sold at a price of $104.41 per share.
• On February 19, 2025, 3,303 shares were sold at a weighted average price of $105.1902, with individual prices ranging from $105.02 to $105.365.
• Following these transactions, Sorenson directly owns 20,991 shares of Boston Scientific common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock sales by an executive. It doesn't inherently convey positive or negative sentiment, as it's a routine disclosure.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies. The use of a 10b5-1 trading plan allows insiders to sell shares at predetermined times and prices, avoiding accusations of insider trading.

Stakeholder Impact

• The stock sales may have a minor impact on shareholders, potentially causing a slight decrease in stock price due to increased supply.
• The impact is likely minimal given the relatively small number of shares sold compared to the company's overall market capitalization.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Sale, Rule 10b5-1, John Bradley Sorenson, Boston Scientific, BSX